Alnylam Pharmaceuticals, Inc. ALNY
Set alert
158.00 USD -7.00 -4.24%
At close · Nov 2
159.06 +1.06 +0.67%
After hours · Nov 2, 6:19 PM ET
156.00 Day range 163.90
158.00 52-week range 473.29
- YTD
- -60.27%
- 1 year
- -65.35%
- Open
- 163.10
- Prev close
- 165.00
- Mkt cap
- 21.16B
- Vol
- 4.76M
- Avg vol
- 1.83M
- EPS
- 19.80
- P/E
- 7.98
- Div yield
- 0.00%
More statistics
- Low
- 156.00
- High
- 163.90
- Forward P/E
- 14.17
- Beta
- 0.44
- Short ratio
- 5.02
- Inst. own
- 101.57%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2027
- 50-d avg
- 236.49
- 200-d avg
- 285.48
- 1y target
- 305.70
5D chart
Events in this range
- Oct 29, 2026Earnings: 16.26; estimate 1.66; surprise 879.52%
- Oct 30, 2026Downgrade: Bernstein · Outperform → Market Perform
- Oct 30, 2026Rating: TD Cowen · Buy → Buy
- Oct 30, 2026Rating: UBS · Buy → Buy
- Nov 2, 2026Rating: Canaccord Genuity · Buy → Buy
- Nov 2, 2026Downgrade: Truist Securities · Buy → Hold
- Nov 2, 2026Rating: Barclays · Overweight → Overweight
Signals (144)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | Nov 2, 3:55 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 11 hours ago |
| SMA: Bearish | Nov 2, 2:40 PM | 11 hours ago |
| MACD: Sell Signal | Nov 2, 2:40 PM | 11 hours ago |
| SMA: Bearish | Nov 2, 2:35 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 1:45 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 1:45 PM | 12 hours ago |
| MACD: Buy Signal | Nov 2, 1:45 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 1:35 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 1:35 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 1:10 PM | 13 hours ago |
| MACD: Sell Signal | Nov 2, 1:10 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 1:05 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 12:40 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 12:30 PM | 13 hours ago |
Newest 20 of 144.
Analyst view
Consensus: buy
Buy
Price target (mean) 305.70 +93.5% upside
Now 158.00
- Target (low)
- 180.00
- Target (mean)
- 305.70
- Target (high)
- 455.00
Ratings (0m) 30 22 buy · 8 hold · 0 sell
- Strong buy7
- Buy15
- Hold8
- Sell0
- Strong sell0
Recommendation trend
- This month 30
- 1 month ago 29
- 2 months ago 29
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.38 | 1.47 – 3.11 | 1.25 | +90.7% | 1.52B | +38.6% | 13 |
| Next quarter | 2.81 | 1.80 – 3.59 | 1.99 | +41.3% | 1.56B | +33.2% | 8 |
| Current year | 22.67 | 21.55 – 24.71 | 5.08 | +346.3% | 5.44B | +46.5% | 13 |
| Next year | 11.36 | 8.74 – 17.71 | 22.67 | -49.9% | 6.60B | +21.2% | 17 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Barclays | Maintained | Overweight | Overweight |
| Nov 2, 2026 | Truist Securities | Downgrade | Buy | Hold |
| Nov 2, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 30, 2026 | UBS | Maintained | Buy | Buy |
| Oct 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 30, 2026 | Bernstein | Downgrade | Outperform | Market Perform |
| Oct 30, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 30, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Oct 30, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 30, 2026 | Raymond James | Downgrade | Strong Buy | Outperform |
| Oct 29, 2026 | Needham | Maintained | Buy | Buy |
| Oct 14, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 14, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 30, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Sep 21, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 8, 2026 | Jefferies | Maintained | Hold | Hold |
| Sep 2, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 19, 2026 | BMO Capital | Initiated | Outperform | Outperform |
| Aug 14, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Aug 4, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 4, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 3, 2026 | Raymond James | Upgrade | Outperform | Strong Buy |
| Aug 3, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 3, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 31, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 31, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 31, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 31, 2026 | Oppenheimer | Maintained | Outperform | Outperform |